Activity of the multikinase inhibitor dasatinib against ovarian cancer cells

Once-Daily Dasatinib for Treatment of Patients with Chronic Myeloid Leukemia

(2009) Timothy Tyler   ANNALS OF PHARMACOTHERAPY

Coexpression of EphB4 and ephrinB2 in tumour advancement of ovarian cancers

(2008) S M Alam et al.   BRITISH JOURNAL OF CANCER

Mitosis: Moesin and the Importance of Being Round

(2008) Jody Rosenblatt   CURRENT BIOLOGY

Caveolin-1 Up-regulation during Epithelial to Mesenchymal Transition Is Mediated by Focal Adhesion Kinase

(2008) Kelly M. Bailey et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Preclinical evaluation of dasatinib, a potent Src kinase inhibitor, in melanoma cell lines

(2008) Alex J Eustace et al.   Journal of Translational Medicine

The EphA2 Receptor and EphrinA1 Ligand in Solid Tumors: Function and Therapeutic Targeting

(2008) J. Wykosky et al.   MOLECULAR CANCER RESEARCH

Extra-Nuclear Signaling of Progesterone Receptor to Breast Cancer Cell Movement and Invasion through the Actin Cytoskeleton

(2008) Xiao-Dong Fu et al.   PLoS One